0001214659-19-004756.txt : 20190725
0001214659-19-004756.hdr.sgml : 20190725
20190725163025
ACCESSION NUMBER: 0001214659-19-004756
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190723
FILED AS OF DATE: 20190725
DATE AS OF CHANGE: 20190725
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DITTAMORE RAYMOND V
CENTRAL INDEX KEY: 0001203772
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37897
FILM NUMBER: 19974783
MAIL ADDRESS:
STREET 1: P O BOX 2050
CITY: GLENWOOD SPRINGS
STATE: CO
ZIP: 81602
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OBALON THERAPEUTICS INC
CENTRAL INDEX KEY: 0001427570
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5421 AVENIDA ENCINAS
STREET 2: SUITE F
CITY: San Diego
STATE: CA
ZIP: 92008
BUSINESS PHONE: 858-480-2400
MAIL ADDRESS:
STREET 1: 5421 AVENIDA ENCINAS
STREET 2: SUITE F
CITY: San Diego
STATE: CA
ZIP: 92008
4
1
marketforms-45352.xml
PRIMARY DOCUMENT
X0306
4
2019-07-23
0001427570
OBALON THERAPEUTICS INC
OBLN
0001203772
DITTAMORE RAYMOND V
C/O OBALON THERAPEUTICS, INC.
5421 AVENIDA ENCINAS, SUITE F
CARLSBAD
CA
92008
true
false
false
false
Common Stock (Restricted Stock Units)
2019-07-23
4
A
false
78125
0
A
105597
D
This award will vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the annual meeting of the Issuer's stockholders immediately following the grant date.
Share amounts do not reflect the impact of a 1-for-10 reverse stock split that became effective after the grant date for the options referenced herein.
/s/ Nooshin Hussainy as attorney-in-fact for Ray Dittamore
2019-07-25